PubMed · 14322106
The source did not provide an abstract. Follow the original record for more information.
Explore connections, maps & timelines
E D EANES. 1964. LOW-ANGLE X-RAY DIFFRACTION.. https://doi.org/10.1111/j.1365-2818.1964.tb00529.x
Cite the original work for its findings. Save a collection to share your selection of sources.
KEEP EXPLORING
Synthetic porous calcium hydroxyapatite (noted p-HAp) treated with different fluoride concentrations at room temperature in the presence of carbonate, sodium chloride and phosphate-rich media was investigated. The fluoridation rate of the porous calcium hydroxyapatite was 89% using 1 mol/L [F(-)] solution compared with 30% for crystalline hydroxyapatite (c-HAp). The high specific surface area of p-HAp (235 m(2)g(-1)) compared with c-HAp sample (47 m(2)g(-1)) has an important effect on the removal of fluoride ions from aqueous solution, when p-HAp was treated with high fluoride concentration to produce calcium fluorohydroxyapatite materials. Fluoride adsorption on porous hydroxyapatites (p-HAp) modified their structural and conduction properties.
In spite of the present knowledge about saliva components and their respective functions, the mechanism(s) of pellicle and dental plaque formation have hitherto remained obscure. This has prompted recent efforts on in vitro studies using hydroxyapatite (HA) as an enamel model. In the present study salivary proteins adsorbed to HA were extracted with TFA and EDTA and resolved by 2D electrophoresis over a pH range between 3 and 10, digested, and then analysed by MALDI-TOF/TOF mass spectrometry and tandem mass spectrometry. Nineteen different proteins were identified using automated MS and MS/MS data acquisition. Among them, cystatins, amylase, carbonic anhydrase, and calgranulin B, were identified.
OBJECTIVES: Voice disorders affect more than 3% of the general population. Vocal fold atrophy is a part of the normal aging process, with up to 60% of 60-year-old individuals displaying evidence of glottal insufficiency. A safe, effective, and durable substance for injection augmentation of the vocal folds is not currently available. The purpose of this investigation was to describe our preliminary experience with calcium hydroxylapatite (CaHA) for vocal fold augmentation. METHODOLOGY: All patients undergoing injection augmentation of the vocal folds with CaHA between January 1, 2002 and June 1, 2003 were prospectively evaluated. Data concerning indications, technique, functional outcome, and complications were collected. In addition, the larynx donated from a woman who underwent vocal fold augmentation with CaHA and subsequently died from terminal cancer was histologically examined. RESULTS: A total of 39 vocal folds in 23 individuals were injected with CaHA. The mean age of the cohort was 62. Fifty-two percent were male. The indications for augmentation were unilateral vocal fold paralysis (9/23), unilateral vocal fold paresis (5/23), presbylarynx (3/23), Parkinson's (3/23), bilateral vocal fold paresis (2/23), and abductor spasmodic dysphonia (1/20). There were no adverse reactions. All individuals reported improvement on a self-administered disease-specific outcome measure (P < 0.001). The pathology from the donated larynx 3 months after injection revealed intact CaHA spherules in good position with a minimal, monocellular inflammatory reaction to the gel carrier and no evidence of implant rejection. CONCLUSIONS: Initial experience with vocal fold augmentation using CaHA is promising. Long-term safety and efficacy needs to be established.